Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma

被引:9
|
作者
Qu, Yaqi [1 ]
Chen, Yujia [2 ]
Zhang, Le [3 ]
Tian, Lifei [1 ]
机构
[1] Shaanxi Prov Peoples Hosp, Dept Gen Surg, Xian 710068, Peoples R China
[2] Hebei Med Univ, Sch Basic Med Sci, Shijiazhuang, Hebei, Peoples R China
[3] Shaanxi Prov Peoples Hosp, Dept Funct, Xian, Peoples R China
关键词
Colon adenocarcinoma; Alternative splicing; Prognostic risk score; Differentially expressed genes;
D O I
10.1186/s12957-020-02010-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Colon adenocarcinoma (COAD) is one of the most common malignant tumors, with high incidence and mortality rates worldwide. Reliable prognostic biomarkers are needed to guide clinical practice. Methods: Comprehensive gene expression with alternative splicing (AS) profiles for each patient was downloaded using the SpliceSeq database from The Cancer Genome Atlas. Cox regression analysis was conducted to screen for prognostic AS events. The R package limma was used to screen differentially expressed genes (DEGs) between normal and tumor samples in the COAD cohort. A Venn plot analysis was performed between DEGs and prognostic AS events, and the DEGs that co-occurred with prognostic AS events (DEGAS) were identified. The top 30 most-connected DEGAS in protein-protein interaction analysis were identified through Cox proportional hazards regression to establish prognostic models. Results: In total, 350 patients were included in the study. A total of 22,451 AS events were detected, of which 2004 from 1439 genes were significantly associated with survival time. By overlapping these 1439 genes with 6455 DEGs, 211 DEGs with AS events were identified. After the construction of the protein-protein interaction network, the top 30 hub genes were included in a multivariate analysis. Finally, a risk score based on 12 genes associated with overall survival was established (P < 0.05). The area under the curve was 0.782. The risk score was an independent predictor (P < 0.001). Conclusions: By exploring survival-associated AS events, a powerful prognostic predictor consisting of 12 DEGAS was built. This study aims to propose a novel method to provide treatment targets for COAD and guide clinical practice in the future.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer
    Wang, Caixia
    Zheng, Mingjun
    Wang, Shuang
    Nie, Xin
    Guo, Qian
    Gao, Lingling
    Li, Xiao
    Qi, Yue
    Liu, Juanjuan
    Lin, Bei
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [22] Identification of Key Prognostic Alternative Splicing Events of Costimulatory Molecule-Related Genes in Colon Cancer
    Ding, Hao
    Shi, Huiwen
    Chen, Weifeng
    Liu, Zhisheng
    Yang, Zhi
    Li, Xiaochuan
    Qiu, Zhichao
    Zhuo, Hongqing
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (13) : 1900 - 1912
  • [23] Prognostic value and potential function of splicing events in prostate adenocarcinoma
    Huang, Zhi-Guang
    He, Rong-Quan
    Mo, Zeng-Nan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (06) : 2473 - 2487
  • [24] Construction and validation of a prognostic risk model for uterine corpus endometrial carcinoma based on alternative splicing events
    Yi Cheng
    Long Li
    Chen Gong
    Kai Qin
    Oncology and Translational Medicine, 2022, 8 (06) : 276 - 284
  • [25] Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
    Ouyang, Dong
    Yang, Ping
    Cai, Jing
    Sun, Si
    Wang, Zehua
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [26] Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
    Dong Ouyang
    Ping Yang
    Jing Cai
    Si Sun
    Zehua Wang
    Cancer Cell International, 20
  • [27] Characterization of alternative splicing events and prognostic signatures in breast cancer
    Pihua Han
    Jingjun Zhu
    Guang Feng
    Zizhang Wang
    Yanni Ding
    BMC Cancer, 21
  • [28] Characterization of alternative splicing events and prognostic signatures in gastric cancer
    Zhu, Nan
    Zhao, Yupeng
    Yan, Wenjing
    Wei, Lan
    Sang, Qingqing
    Li, Jianfang
    Liu, Bingya
    Yu, Beiqin
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [29] Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
    Chen, Peigen
    He, Junxian
    Ye, Huixia
    Jiang, Senwei
    Li, Yunhui
    Li, Xiaomao
    Wan, Jing
    FRONTIERS IN GENETICS, 2020, 11
  • [30] Characterization of alternative splicing events and prognostic signatures in breast cancer
    Han, Pihua
    Zhu, Jingjun
    Feng, Guang
    Wang, Zizhang
    Ding, Yanni
    BMC CANCER, 2021, 21 (01)